-
A call for community engagement: Exploring the harms and benefits of molecular HIV surveillance
Posted on by “The first letter in HIV stands for Human,” writes Dr. Alexander McClelland in a co-authored…
-
Communities teaching communities: A framework for Indigenous community development
With community partners across Alberta and Saskatchewan, the DRUM & SASH team is building a knowledge base to support Indigenous capacity strengthening
-
Putting data into action: How CTN researchers track, prevent, and manage HIV in infants
The Canadian Pediatric and Perinatal HIV/AIDS Research Group is a collection of clinicians and researchers that form the primary resource for pediatric HIV in Canada
-
Everyone ages differently: Cardiovascular disease and HIV
The CTN’s HIV and Aging Cohort Study aims to understand how HIV can affect the development of heart disease, and what can be done to address it
-
Age, altruism, or a long-term view: Why do people living with HIV get the COVID-19 vaccine?
Understanding COVID-19 vaccine confidence in people living with HIV in Canada
-
CTN study tests new drug for the first time in people living with HIV
The drug works against CMV, a common virus that may be a main cause of inflammation and health problems in people living with HIV
-
New research comparing HIV medications set to change international recommendations
The WHO-funded study shows that dolutegravir is the optimal choice for first-line treatment of HIV
-
Here’s what we know about COVID-19 & HIV
Many questions remain about COVID-19 and what it means for people living with HIV. We explore the research so far
-
Could Cannabis Help Prevent HIV-Related Illnesses?
During the height of the AIDS epidemic in the 1980s, it was used to combat nausea, wasting, and…
